TKPHF (Takeda Pharmaceutical Co) Institutional Ownership: 37.83% (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TKPHF Takeda Pharmaceutical Co Ltd TKPHF
77 GF Score
Price $35.89
GF Value $29.62
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Takeda Pharmaceutical Co Institutional Ownership?

Takeda Pharmaceutical Co TKPHF +2.72% 77 Institutional Ownership is 37.83% as of Aug. 01, 2026. GuruFocus rates TKPHF with a GF Score™ of 77/100 and a GF Value™ of $29.62 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Takeda Pharmaceutical Co's institutional ownership is 37.83%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Takeda Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Takeda Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 99.93%.

Takeda Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Takeda Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co Institutional Ownership Chart

Takeda Pharmaceutical Co Historical Data

The historical data trend for Takeda Pharmaceutical Co can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 38.77 38.71 39.33 39.73 39.28 40.43 42.13 42.19 42.48 43.35
TKPHF
77GF Score
Takeda Pharmaceutical Co Ltd TKPHF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Takeda Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 37.83% mean?
Takeda Pharmaceutical Co (TKPHF) has a Institutional Ownership of 37.83% as of Aug. 01, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Takeda Pharmaceutical Co and its competitors.
Is Takeda Pharmaceutical Co's Institutional Ownership too high?
Takeda Pharmaceutical Co's current Institutional Ownership is 37.83%. Overall, Takeda Pharmaceutical Co has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Institutional Ownership compare to ZTS and UTHR?
Takeda Pharmaceutical Co's Institutional Ownership of 37.83% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Takeda Pharmaceutical Co and its competitors. Takeda Pharmaceutical Co's current Institutional Ownership is 37.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TKPHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $29.62, compared to a current price of $35.89 — trading 21.2% above its estimated fair value. The current Institutional Ownership is 37.83%. Takeda Pharmaceutical Co's overall GF Score™ is 77/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TKPHF), the current Institutional Ownership is 37.83% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takeda Pharmaceutical Co (TKPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued. The current stock price of $35.89 is trading 21.2% above its estimated GF Value™ of $29.62. GuruFocus considers Takeda Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for TKPHF:

  • Institutional Ownership: 37.83%
  • GF Value™: $29.62 vs. price of $35.89 (21.2% above fair value)
  • GF Score™: 77/100 with 10 warning signs

No single metric tells the full story. See the TKPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takeda Pharmaceutical Co Business Description

Address 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
77GF Score

Get the complete analysis for TKPHF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$35.89
Price
$29.62
GF Value